Drug and Device
Maryland Adopts Daubert Test
In Rochkind v. Stevenson, 2020 WL 5085877 (Md. Aug. 28, 2020), the Maryland Court of Appeals (that is the state’s highest court), recently adopted the Daubert standard for assessing the reliability of proffered expert opinion evidence. This is the test used in federal courts and most other states, but not all. The court’s move away from the Frye test reflected a “jurisprudential drift” over the past 40 or so years towards more careful scrutiny of expert evidence in an effort to prevent unreliable science from entering into a trial. 471 Md. 1, 5, 236 A.3d 630, 633..
The case involved the claim that plaintiff’s Attention Deficit Hyperactivity Disorder (ADHD) had been caused by her childhood exposure to lead. She sued the landlord of the apartment where she had lived, and sought to rule out other risk factors, such as a family history of learning disabilities, through expert testimony. The landlord challenged the reliability of the proposed expert’s causation methodology and conclusions.
Continue Reading Maryland Adopts Daubert Test
Innovator Liability and Personal Jurisdiction
The short opinion in Stirling v. Novartis Pharm. Corp., 2020 WL 4259035 (Idaho Dist. Ct., July 13, 2020), comes at the intersection of personal jurisdiction rules and innovator liability claims. As readers will recall, plaintiffs who allege injury from ingestion of a generic version of a prescription drug cannot prevail on a failure to…
FDA Settles Amarin First Amendment Challenge
Amarin Pharma and the FDA recently announced a widely expected settlement of First Amendment litigation over restrictions on the company’s promotion of its Vascepa product.
Readers may recall that this was one of several recent challenges to the FDA’s attempt to restrict off-label promotion of prescription products, even if that speech is truthful and not…
New Clinical Robotics Blog
My colleagues at Shook Hardy & Bacon have launched the Shook Clinical Robotics Law Blog to examine legal trends and developments in clinical robot…
Continue Reading New Clinical Robotics Blog
Preemption Found in Another Drug MDL
Implied preemption makes complete sense when it is evident that the FDA would not have permitted label changes that plaintiffs in private litigation s…
Continue Reading Preemption Found in Another Drug MDL
Stay in Amarin Extended
The court recently extended its stay of the proceedings in Amarin Pharma Inc.’s suit against the FDA challenging threatened agency action concerning t…
Continue Reading Stay in Amarin Extended
Abandonment Issues in an MDL
The defendant in a medical device MDL recently flagged an important and thorny issue that impacts many if not most MDL’s. And it has to do with bellwe…
Continue Reading Abandonment Issues in an MDL
Federal Court Rejects Jurisdiction Over French Manufacturer
A federal court in Mississippi has rejected the assertion of personal jurisdiction over a French medical device company. See Arnoult v. CL Med. Sarl, …
Continue Reading Federal Court Rejects Jurisdiction Over French Manufacturer
Drug Class Action Rejected Again
Class certification was denied — again — in litigation brought by plaintiffs who allege a drug maker misstated the likelihood of withdrawal symptoms…
Continue Reading Drug Class Action Rejected Again